Complete DNA analysis for young adults with cancer
KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are young people aged 18 to 39, also known as AYAs: Adolescents and Young Adults. With this grant, Hartwig Medical Foundation will use the latest techniques to visualize the complete DNA of the tumor for 1,000 patients over the next four years. This means that the treatment can be better attuned to the specific tumor characteristics of each patient.
GENAYA
The genetic information and treatment data are stored with the patient’s consent in a globally unique database and made available for scientific research. In this way, not only these 1,000 patients will benefit from the research, but also the patients in the future. The project named GENAYA (a national database of GENome data of Adolescent and Young Adult cancers) builds on an infrastructure already funded by KWF; COMPRAYA. Hartwig Medical Foundation will provide diagnostic DNA analysis based on whole genome sequencing for GENAYA. Thanks to the grant from KWF, the complete DNA analysis are also made available to AYA patients in non-academic centers.
Hartwig Medical Foundation
Hartwig Medical is a not-for-profit foundation. The foundation aims to improve care for patients with cancer. It does this by advancing cancer research and conducting complete DNA analysis in cancer patients. This should contribute to ensuring that every cancer patient receives the treatment that best suits her or him.
More information
- Complete DNA test
- Hartwig Medical database
- Publications with data from Hartwig Medical database
All news
Also read
Collaboration for future-proof diagnostics and to accelerate research
Complete analysis of the DNA of children with cancer offers many possibilities. It maps out all possible targeted treatment options …
Whole Genome Sequencing feasible in clinical practice
Interim WIDE analysis gives researchers more confidence in a positive outcome. On 21 September 2020, Dr. Kim Monkhorst, who is a …
Towards a learning healthcare system by broad collaboration
Developing a new drug is expensive and takes a long time. In addition, there is only a slim chance that …
The complete DNA test is an additional tool to help us discover the origin of the cancer in patients with CUP, often enabling us to identify this primary tumor. In addition, the test often reveals new options for targeted treatment.